General Manager
Tanabe Pharma Corporation · AMCG · Tanabe Pharma GmbH
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
46
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
6
PubMed author-name match
Trials
Studies that name General Manager as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:14 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07793513 · Study of BK1803 in Healthy InfantsTanabe Pharma Corporation · not yet recruiting · Pertussis, Diphtheria, Tetanus · study director
- Ph1NCT06994286 · The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.Tanabe Pharma Corporation · completed · Healthy Subjects · study director
- Ph1NCT06482346 · Clinical Pharmacology Study of MT-3534 in Healthy Adult Male VolunteersTanabe Pharma Corporation · completed · Healthy Adult Male Volunteers · study director
- Ph1NCT06196905 · An Exploratory Study of MT-2990 in Patients With AAVTanabe Pharma Corporation · completed · Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV) · study director
- N/ANCT05825911 · Evaluation of Diagnostic Accuracy of MCG(Magnetocardiography) Scan in Suspected Coronary Artery DiseaseAMCG · completed · Coronary Artery Disease · study director
- Ph4NCT05740371 · Safety of Argatroban Infusion in Conduction DisturbancesTanabe Pharma GmbH · completed · Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative) · study director
- Ph1/Ph2NCT05658562 · A Study of MT-2111 in Patients With Relapsed/Refractory DLBCLTanabe Pharma Corporation · active not recruiting · Diffuse Large B-Cell Lymphoma · study director
- Ph1NCT05396235 · A Clinical Pharmacology Study of MT-3921 in Healthy Adult MalesTanabe Pharma Corporation · completed · Healthy Adult Males · study director
- Ph1NCT05240612 · A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)Tanabe Pharma Corporation · completed · HTLV-1-Associated Myelopathy (HAM) · study director
- Ph3NCT05198557 · A Study of MT-0551 in Patients With Systemic SclerosisTanabe Pharma Corporation · active not recruiting · Systemic Sclerosis · study director
- Ph2NCT05123196 · Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral NeuropathyTanabe Pharma Corporation · completed · Painful Diabetic Peripheral Neuropathy · study director
- Ph3NCT03891758 · Confirmatory Study of BK1310 in Healthy InfantsTanabe Pharma Corporation · completed · Tetanus, Diphtheria, Pertussis · study director
- Ph1NCT03688022 · Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump InhibitorTanabe Pharma America, Inc. · completed · Healthy Volunteer · study director
- Ph3NCT03645863 · Effects of Iron Supplements on the Pharmacokinetics of MT-6548Tanabe Pharma Corporation · completed · Healthy · study director
- Ph1NCT03570957 · A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis PatientsTanabe Pharma Corporation · completed · Seasonal Allergic Rhinitis · study director
- Ph1NCT03507738 · Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and InfantsTanabe Pharma Corporation · completed · Healthy · study director
- Ph1NCT03503266 · Mass Balance Study With MT-7117Tanabe Pharma America, Inc. · completed · Healthy Volunteer · study director
- Ph3NCT03461146 · Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanTanabe Pharma Corporation · completed · Anemia; Hemodialysis Dependent Chronic Kidney Disease · study director
- Ph3NCT03439137 · Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanTanabe Pharma Corporation · completed · Anemia; Hemodialysis Dependent Chronic Kidney Disease · study director
- Ph3NCT03436693 · Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic NephropathyTanabe Pharma Corporation · completed · Diabetic Nephropathy · study director
- Ph3NCT03402386 · Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in JapanTanabe Pharma Corporation · completed · Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease · study director
- Ph3NCT03329196 · Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in JapanTanabe Pharma Corporation · completed · Anemia; Non-dialysis Dependent Chronic Kidney Disease · study director
- Ph2/Ph3NCT03245008 · Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe PainTanabe Pharma Corporation · completed · Osteoarthritis, Knee / Osteoarthritis, Hip · study director
- Ph3NCT03188692 · Safety and Efficacy of BK1310 Intramuscular Injection in Healthy InfantsTanabe Pharma Corporation · completed · Immunization · study director
- Ph2/Ph3NCT03176771 · Efficacy and Safety of MT-5199 in Subjects With Tardive DyskinesiaTanabe Pharma Corporation · completed · Tardive Dyskinesia · study director
- Ph2NCT03172598 · Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral NeuropathyTanabe Pharma Corporation · completed · Painful Diabetic Peripheral Neuropathy · study director
- Ph1NCT03156738 · A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy VolunteersTanabe Pharma Corporation · completed · Healthy · study director
- Ph3NCT02992925 · Phase 3 Study of BK1310 in Healthy InfantsTanabe Pharma Corporation · completed · Immunization; Infection · study director
- Ph1NCT02953132 · A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy VolunteersTanabe Pharma Corporation · completed · Healthy · study director
- Ph3NCT02924064 · Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusTanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT02923154 · Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)Tanabe Pharma Corporation · completed · NASH · study director
- Ph3NCT02916706 · Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes MellitusTanabe Pharma Corporation · completed · Type 2 Diabetes Mellitus · study director
- Ph1NCT02900235 · Mass Balance Study of MT-3995Tanabe Pharma Corporation · completed · Healthy · study director
- Ph4NCT02400775 · A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.Takeda · withdrawn · Essential Hypertension With Stable Angina and Dyslipidemia · study director
- Ph1NCT02367872 · Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentTakeda · completed · Renal Impairment, Hepatic Impairment · study director
- Ph1/Ph2NCT02367885 · Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric ParticipantsTakeda · completed · Influenza Infection · study director
- Ph1NCT02322606 · A Phase 1, Single and Multiple Dose Study of TAK-137Takeda · withdrawn · Healthy Japanese Adult Male · study director
- Ph1NCT02286518 · TAK-114 Single- and Multiple-Dose Phase 1 StudyTakeda · completed · Clinical Pharmacology · study chair
- Ph3NCT02276274 · Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male SubjectsTakeda · completed · Clinical Pharmacology · study director
- Ph1NCT02113020 · A Phase I Clinical Pharmacology Study of TAK-233 in Healthy SubjectsTakeda · completed · Clinical Pharmacology · study director
- Ph1/Ph2NCT02111252 · A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult SubjectsTakeda · completed · Influenza · study director
- Ph4NCT02079805 · A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RTakeda · completed · Essential Hypertension Complicated by Type 2 Diabetes Mellitus · study director
- Ph3NCT02037477 · Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)Takeda · completed · Healthy Volunteers · study director
- Ph3NCT01751360 · SYR-472 Open-label StudyTakeda · completed · Diabetes Mellitus · study director
- Ph3NCT00787254 · Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory DrugsTakeda · completed · Stomach Ulcer, Duodenal Ulcer · study director
- Ph3NCT00762359 · A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersTakeda · terminated · Stomach Ulcer, Duodenal Ulcer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:14 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Evaluation of PRF and PLA-PGA Membrane Along with Hydroxyapatite Crystal Collagen Fibers Bone Graft in the Treatment of Infrabony Defects.J Contemp Dent Pract · 20238 citationsRCR 1.7
- Evaluation of the Efficacy of a 1:1 Mixture of β-TCP and rhPDGF-BB in the Surgical Management of Two- and Three-Wall Intraosseous Defects: A Prospective Clinical Trial.Int J Periodontics Restorative Dent · 20197 citationsRCR 0.6
- Comparison of conventional unstained lymph nodal harvesting vs methylene blue-stained lymph nodal harvesting in colorectal specimen in staging left-sided colorectal carcinoma: a randomized controlled trial.J Gastrointest Surg · 20242 citationsRCR 0.3
- Enhanced recovery programs following adhesive small bowel obstruction surgery are feasible and reduce the rate of postoperative ileus: a preliminary study.Langenbecks Arch Surg · 20242 citationsRCR 0.9
- Impact of 3-dimensional myofascial release on tumor necrosis factor (TNF) alpha biomarker in nonspecific low back pain: a randomised controlled trial.Eur Spine J · 20250 citationsRCR 0.0